InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.334
-0.046 (-3.34%)
Nov 20, 2024, 4:00 PM EST - Market closed

Company Description

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally.

The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector.

The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

InterCure Ltd.
InterCure logo
Country Israel
Founded 1994
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 270
CEO Alexander Rabinovich

Contact Details

Address:
85 Medinat ha-Yehudim Street
Herzliya, 4676670
Israel
Phone 972 7 746 05012
Website intercure.co

Stock Details

Ticker Symbol INCR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency ILS
CIK Code 0001857030
CUSIP Number M549GJ111
ISIN Number IL0011063760
SIC Code 2834

Key Executives

Name Position
Alexander Rabinovich Chief Executive Officer and Director
Amos Cohen Chief Financial Officer
Einat Zehavi Vice President of Sales

Latest SEC Filings

Date Type Title
Nov 4, 2024 6-K Report of foreign issuer
Oct 28, 2024 6-K Report of foreign issuer
Sep 17, 2024 6-K/A Filing
Sep 13, 2024 6-K Report of foreign issuer
Aug 29, 2024 6-K Report of foreign issuer
Aug 28, 2024 6-K Report of foreign issuer
May 21, 2024 6-K Report of foreign issuer
May 1, 2024 6-K Report of foreign issuer
May 1, 2024 20-F Annual and transition report of foreign private issuers
May 1, 2024 NT 20-F Notification of inability to timely file Form 20-F